Hypertrichosis as a side effect of inhaled steroids in children

Pediatric Pulmonology

Volumn 42, Issue 4, 2007, Pages 370-373

  De Vries, T W ^a   De Langen Wouterse, J J ^b   De Jong Van Den Berg, L T W ^c   Duiverman, E J ^d  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Asthma; Hair; Hypertrichosis; Individual susceptibility; Inhaled corticosteroids; Side effects

Indexed keywords

BECLOMETASONE; BETAMETHASONE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE; STEROID; TERBUTALINE; TRIAMCINOLONE;

ADOLESCENT; ADRENAL SUPPRESSION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DATA BASE; DISEASE PREDISPOSITION; DRUG SURVEILLANCE PROGRAM; FEMALE; GROWTH RETARDATION; HUMAN; HYPERTRICHOSIS; MALE; NETHERLANDS; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ANDROSTADIENES; ASTHMA; BECLOMETHASONE; BUDESONIDE; CHILD; CHILD, PRESCHOOL; DATABASES; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HUMANS; HYPERTRICHOSIS; INFANT; MALE; NEBULIZERS AND VAPORIZERS;

EID: 34247205948     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20589     Document Type: Article

References (13)

1. Anonymous. British guidelines on the management of asthma: pharmacological management. Thorax 2003;58:s17-s31.
2. e herziening). II Medicamenteuze behandeling. Ned Tijdschr Geneeskd 2003;147:1909-1912.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. National Institutes of Health. National Heart, Lung, and Blood Institute. Bethesda, Maryland USA 2002.
4. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999;159:941-955.
5. Vries de TW, Langen-Wouterse de JJ, Puijenbroek van EP, Duiverman EJ, Jong-Van den Berg de LTW. Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands. Eur J Clin Pharm 2006;62:343-346.
6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse effects. Clin Pharmacol Ther 1981; 30:239-245.
7. Wachter de E, Malfroot A, Schutter de I, Vanbesien J, Schepper de J. Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros 2003;2:72-75.
8. Hollmann GA, Allen DB. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988;81:452-455.
9. Patel L, Wales JK, Kibirige MS, Massarano AA, Couriel JM, Clayton PE. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 2001;85:330-334.
10. Perry CA, Findlay CA, Donaldson MD. Cushing's syndrome, growth impairment and occult adrenal suppression associated with intranasal steroids. Arch Dis Child 2002;86:45-48.
11. Rosenfeld RL. Hirsutism. N Engl J Med 2005;353:2578-2588.
12. Curran DR, Moore C, Huber T. What is the best approach to the evaluation of hirsutism? J Fam Pract 2005;54:465-467.
13. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006;367:1605-1617.